Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib

Prof Evangelos Terpos - University of Athens, Athens, Greece

22 Dec 2020

Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients

Prof Evangelos Terpos - University of Athens, Athens, Greece

$Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )$

22 Dec 2020

Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel

Prof Evangelos Terpos - University of Athens, Athens, Greece

22 Dec 2020

2020 updates in treating NTRK fusion cancer

Dr Alexander Drilon and Prof Marc Peeters

22 Dec 2020

SABCS 2020: Conference roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

16 Dec 2020

ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith

$ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )$

15 Dec 2020

Latest data for managing ALK NSCLC patients

Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea

11 Dec 2020

Clinical activity and safety of cevostamab in relapsed/refractory multiple myeloma

Prof Adam Cohen - University of Pennsylvania, Philadelphia, USA

$Clinical activity and safety of cevostamab in relapsed/refractory multiple myeloma ( Prof Adam Cohen - University of Pennsylvania, Philadelphia, USA )$